Open Market Insiders Trades

This list includes insiders general transaction with codes filed in Form 4 from SEC:

P - Open market or private purchase of non-derivative or derivative security
S - Open market or private sale of non-derivative or derivative security
V - Transaction voluntarily reported earlier than required

Ticker	Insider	Transaction Type	Ownership Type	Shares Traded	Value / Price	Filing Date
SNX	Dennis Polk Hyve Solutions Executive	SELL Open market or private sale	Direct	2,002 Reduced 4.31%	$240,761 $120.26 p/Share	Mar 01 2017
PLNT	Dorvin D Lively President	SELL Open market or private sale	Direct	2,469 Reduced 100.0%	$54,318 $22.0 p/Share	Mar 01 2017
PRTA	Dennis J. Selkoe	SELL Open market or private sale	Direct	3,500 Reduced 55.16%	$207,375 $59.25 p/Share	Mar 01 2017
PRTA	Arthur W Homan Chief Legal Officer	SELL Open market or private sale	Direct	3,125 Reduced 100.0%	$185,250 $59.28 p/Share	Mar 01 2017
PRTA	Gene G. Kinney President and CEO	SELL Open market or private sale	Direct	25,163 Reduced 90.01%	$1,528,904 $60.76 p/Share	Mar 01 2017
TSLA	Kimbal Musk Director	SELL Open market or private sale	Direct	2,500 Reduced 1.47%	$635,575 $254.23 p/Share	Mar 01 2017
PEN	Robert D. Evans EVP, Gen. Counsel & Secretary	SELL Open market or private sale	Indirect	5,000 Reduced 1.99%	$400,150 $80.03 p/Share	Mar 01 2017
PFGC	Blackstone Holdings Iii L.P. > 10% Shareholder	SELL Open market or private sale	Indirect	13,133,201 Reduced 48.36%	$306,003,573 $23.3 p/Share	Mar 01 2017
RARX	Novartis Bioventures LTD > 10% Shareholder	SELL Open market or private sale	Direct	7,778 Reduced 0.32%	$162,638 $20.91 p/Share	Mar 01 2017
WSO	United Technologies Corp /De/ > 10% Shareholder	SELL Open market or private sale	Indirect	4,235,685 Reduced 100.0%	$595,876,135 $140.68 p/Share	Feb 28 2017
NEM	E Randall Engel EVP, Strategic Development	SELL Open market or private sale	Direct	12,720 Reduced 4.62%	$435,278 $34.22 p/Share	Feb 28 2017
URI	Singleton B Mcallister Director	SELL Open market or private sale	Direct	3,300 Reduced 16.76%	$422,532 $128.04 p/Share	Feb 28 2017
PEP	Ramon Laguarta Chairman and CEO	SELL Open market or private sale	Direct	23,585 Reduced 17.01%	$2,571,944 $109.05 p/Share	Feb 28 2017
DHR	Brian W Ellis Senior Vice President - GC	SELL Open market or private sale	Direct	983 Reduced 13.73%	$84,538 $86.0 p/Share	Feb 28 2017
DJCO	John Patrick Et Al Guerin Director	SELL Open market or private sale	Indirect	100 Reduced 0.07%	$21,400 $214.0 p/Share	Feb 28 2017
IBCP	Charles C Van Loan Director	SELL Open market or private sale	Direct	16,993 Reduced 22.26%	$368,238 $21.67 p/Share	Feb 28 2017
SQ	Khosla Ventures Iii, L.P.	SELL Open market or private sale	Indirect	300,000 Reduced 100.0%	$5,232,000 $17.44 p/Share	Feb 28 2017
HZNP	Robert Carey EVP, Chief Business Officer	SELL Open market or private sale	Indirect	1,808 Reduced 1.42%	$29,796 $16.48 p/Share	Feb 28 2017
PRTA	Gene G. Kinney President and CEO	SELL Open market or private sale	Direct	3,796 Reduced 57.61%	$227,760 $60.0 p/Share	Feb 28 2017
JNJ	Ronald A Kapusta Controller, CAO	SELL Open market or private sale	Direct	14,543 Reduced 32.68%	$1,777,882 $122.25 p/Share	Feb 28 2017
JNJ	Gary J Pruden Exec VP, WW Chair, Med Devices	SELL Open market or private sale	Direct	16,299 Reduced 27.2%	$1,991,901 $122.21 p/Share	Feb 28 2017
ABBV	Thomas A. Hurwich VP, Controller	SELL Open market or private sale	Direct	2,311 Reduced 3.32%	$143,028 $61.89 p/Share	Feb 28 2017
ABT	Joseph J Manning EXECUTIVE VICE PRESIDENT	SELL Open market or private sale	Direct	744 Reduced 3.13%	$33,450 $44.96 p/Share	Feb 28 2017
ABT	Hubert L Allen EXECUTIVE VICE PRESIDENT, GC	SELL Open market or private sale	Direct	857 Reduced 0.84%	$38,574 $45.01 p/Share	Feb 28 2017
ABT	Roger Bird SENIOR VICE PRESIDENT	SELL Open market or private sale	Direct	1,601 Reduced 2.74%	$72,077 $45.02 p/Share	Feb 28 2017
ABT	Heather L Mason Executive Vice President	SELL Open market or private sale	Direct	1,912 Reduced 3.1%	$86,059 $45.01 p/Share	Feb 28 2017
ABT	Jaime Contreras Senior Vice President	SELL Open market or private sale	Direct	13,155 Reduced 22.34%	$592,107 $45.01 p/Share	Feb 28 2017
RARX	Novartis Bioventures LTD > 10% Shareholder	SELL Open market or private sale	Direct	7,847 Reduced 0.32%	$163,688 $20.86 p/Share	Feb 28 2017
NEM	E Randall Engel EVP, Strategic Development	SELL Open market or private sale	Direct	2,356 Reduced 1.14%	$84,392 $35.82 p/Share	Feb 27 2017
IBCP	Charles C Van Loan Director	SELL Open market or private sale	Direct	10,417 Reduced 12.01%	$228,341 $21.92 p/Share	Feb 27 2017
NP	Armin Schwinn SVP, Mng Dir, Neenah Germany	SELL Open market or private sale	Direct	3,416 Reduced 78.62%	$265,150 $77.62 p/Share	Feb 27 2017
NP	Steven S Heinrichs SVP, General Counsel & Sec	SELL Open market or private sale	Direct	6,010 Reduced 26.95%	$454,476 $75.62 p/Share	Feb 27 2017
SNPS	Sudhindra Kankanwadi Chief Accounting Officer	SELL Open market or private sale	Direct	9,499 Reduced 82.0%	$685,543 $72.17 p/Share	Feb 27 2017
LLY	Lilly Endowment Inc	SELL Open market or private sale	Direct	225,000 Reduced 0.18%	$18,688,499 $83.06 p/Share	Feb 27 2017
INTU	Brad D Smith Director	SELL Open market or private sale	Direct	103,445 Reduced 33.18%	$13,067,172 $126.32 p/Share	Feb 27 2017
ARE	Thomas J Andrews Co-President	SELL Open market or private sale	Direct	5,000 Reduced 4.03%	$603,000 $120.6 p/Share	Feb 27 2017
PRTA	Christopher S Henney Director	SELL Open market or private sale	Direct	5,989 Reduced 100.0%	$342,331 $57.16 p/Share	Feb 27 2017
HD	Ann Marie Campbell Senior EVP	SELL Open market or private sale	Direct	7,000 Reduced 10.74%	$1,017,030 $145.29 p/Share	Feb 27 2017
DHR	Angela S Lalor SVP, Human Resources	SELL Open market or private sale	Direct	6,044 Reduced 10.05%	$520,993 $86.2 p/Share	Feb 27 2017
DHR	Daniel L Comas EVP	SELL Open market or private sale	Direct	10,250 Reduced 6.1%	$882,422 $86.09 p/Share	Feb 27 2017
DJCO	John Patrick Et Al Guerin Director	SELL Open market or private sale	Indirect	301 Reduced 0.1%	$64,866 $215.5 p/Share	Feb 27 2017
DJCO	John Patrick Et Al Guerin Director	SELL Open market or private sale	Indirect	1 Reduced 0.0%	$217 $217.0 p/Share	Feb 27 2017
RARX	Novartis Bioventures LTD > 10% Shareholder	SELL Open market or private sale	Direct	57,844 Reduced 2.28%	$1,212,410 $20.96 p/Share	Feb 27 2017
BMY	Theodore R. Samuels Ii Director	BUY Open market or private purchase	Direct	12,000 Added 50.0%	$681,240 $56.77 p/Share	Feb 27 2017
MICS	Bernardo Melo Chief Revenue Officer	BUY Open market or private purchase	Direct	5,000 Added 0.91%	$2,650 $0.53 p/Share	Feb 24 2017
MICS	Gary Kevin Atkinson Chief Executive Officer	BUY Open market or private purchase	Direct	5,000 Added 1.6%	$2,650 $0.53 p/Share	Feb 24 2017
NEE	William H Swanson Director	BUY Open market or private purchase	Direct	3,860 Added 13.29%	$497,400 $128.86 p/Share	Feb 24 2017
MDC	David E Blackford Director	SELL Open market or private sale	Direct	16,250 Reduced 54.85%	$479,212 $29.49 p/Share	Feb 24 2017
CSCO	Chris Dedicoat EVP, Worldwide Sales & Fld Ops	SELL Open market or private sale	Direct	34,597 Reduced 13.11%	$1,180,450 $34.12 p/Share	Feb 24 2017
ARE	Thomas J Andrews Co-President	SELL Open market or private sale	Direct	5,000 Reduced 3.88%	$598,400 $119.68 p/Share	Feb 24 2017

Account

Open Market Insiders Trades